Future directions in antiplatelet therapy: efficacy versus safety

Future Prescriber Pub Date : 2009-08-13 DOI:10.1002/fps.52
Nadzeya Kuzniatsova, Eduard Shantsila MD, Gregory YH Lip MD, FRCP
{"title":"Future directions in antiplatelet therapy: efficacy versus safety","authors":"Nadzeya Kuzniatsova,&nbsp;Eduard Shantsila MD,&nbsp;Gregory YH Lip MD, FRCP","doi":"10.1002/fps.52","DOIUrl":null,"url":null,"abstract":"<p>An improved understanding of the underlying mechanisms of platelet activation and thrombogenesis has led to the discovery of new antiplatelet agents. Various clinical studies have investigated the effectiveness of these new agents in comparison with ‘traditional’ antiplatelet drugs. The problem with this approach is that enhanced antiplatelet activity may result in excessive bleeding complications. Consequently, the challenge is to ascertain the fine balance between optimal efficacy and safety for future antiplatelet drugs and their combinations. Copyright © 2009 John Wiley &amp; Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"10 3","pages":"20-23"},"PeriodicalIF":0.0000,"publicationDate":"2009-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.52","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.52","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

An improved understanding of the underlying mechanisms of platelet activation and thrombogenesis has led to the discovery of new antiplatelet agents. Various clinical studies have investigated the effectiveness of these new agents in comparison with ‘traditional’ antiplatelet drugs. The problem with this approach is that enhanced antiplatelet activity may result in excessive bleeding complications. Consequently, the challenge is to ascertain the fine balance between optimal efficacy and safety for future antiplatelet drugs and their combinations. Copyright © 2009 John Wiley & Sons, Ltd.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗血小板治疗的未来方向:疗效与安全性
对血小板活化和血栓形成的潜在机制的进一步了解导致了新的抗血小板药物的发现。各种临床研究已经调查了这些新药与“传统”抗血小板药物的有效性。这种方法的问题是抗血小板活性的增强可能导致过多的出血并发症。因此,挑战在于确定未来抗血小板药物及其组合的最佳疗效和安全性之间的微妙平衡。版权所有©2009 John Wiley &儿子,有限公司
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Promising new drugs and drug targets for HIV treatment Treatment of rheumatoid arthritis: current and future Lurasidone: new development for the treatment of psychosis Sunovion: innovative medicines for areas of unmet clinical need Role and cost effectiveness of bariatric surgery in T2DM
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1